Clinical stage biotech company Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has released a new investor presentation as the company presents at the Ord.
In 2023, the healthcare sector faced challenges in keeping pace with the broader equity market. However, Janus Henderson portfolio managers Andy Acker and.